GB1283892A - Improvements in and relating to medicinal compositions for application to the skin and/or hair - Google Patents
Improvements in and relating to medicinal compositions for application to the skin and/or hairInfo
- Publication number
- GB1283892A GB1283892A GB814/71A GB81471A GB1283892A GB 1283892 A GB1283892 A GB 1283892A GB 814/71 A GB814/71 A GB 814/71A GB 81471 A GB81471 A GB 81471A GB 1283892 A GB1283892 A GB 1283892A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hair
- acid
- protein
- skin
- mucopolysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 abstract 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 abstract 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 abstract 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 2
- 229960000458 allantoin Drugs 0.000 abstract 2
- 239000006071 cream Substances 0.000 abstract 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 abstract 2
- 235000018102 proteins Nutrition 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 abstract 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 abstract 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- GKQHIYSTBXDYNQ-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC=CC=C1 GKQHIYSTBXDYNQ-UHFFFAOYSA-M 0.000 abstract 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 229920001287 Chondroitin sulfate Polymers 0.000 abstract 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 abstract 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 abstract 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 abstract 1
- 239000005905 Hydrolysed protein Substances 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- 239000004166 Lanolin Substances 0.000 abstract 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
- 229920002230 Pectic acid Polymers 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000004163 Spermaceti wax Substances 0.000 abstract 1
- 235000021355 Stearic acid Nutrition 0.000 abstract 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 abstract 1
- 229960001950 benzethonium chloride Drugs 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- 229960000541 cetyl alcohol Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960002433 cysteine Drugs 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- 229960001305 cysteine hydrochloride Drugs 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- 229960001484 edetic acid Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 229940097043 glucuronic acid Drugs 0.000 abstract 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 abstract 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 abstract 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 abstract 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 abstract 1
- 229960004068 hexachlorophene Drugs 0.000 abstract 1
- 229940051250 hexylene glycol Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 abstract 1
- 235000019388 lanolin Nutrition 0.000 abstract 1
- 229940039717 lanolin Drugs 0.000 abstract 1
- 229940046892 lead acetate Drugs 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 239000002480 mineral oil Substances 0.000 abstract 1
- 235000010446 mineral oil Nutrition 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
- 239000003208 petroleum Substances 0.000 abstract 1
- 210000002826 placenta Anatomy 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 239000004848 polyfunctional curative Substances 0.000 abstract 1
- 239000010318 polygalacturonic acid Substances 0.000 abstract 1
- 210000004761 scalp Anatomy 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 235000011083 sodium citrates Nutrition 0.000 abstract 1
- 235000019385 spermaceti wax Nutrition 0.000 abstract 1
- 239000008117 stearic acid Substances 0.000 abstract 1
- 229960004418 trolamine Drugs 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
- A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/02—Shaving preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
1283892 Hair nail and skin treating compositions I I LUBOWE 7 Jan 1971 [8 June 1970] 814/71 Heading A5B [Also in Division C5] A composition for application to hair, nails or skin comprises an aqueous solution of a quaternary ammonium compound and 0.1- 15% of at least one mucopolysaccharide or N- acetyl glucosamine. The quaternary ammonium compound may have antioxidant and antimicrobial action. Compounds specified are benzalkonium chloride, benzethonium chloride and lauryl pyridinium chloride. The mucopolysaccharide may be hyaluronic acid or chondroitin sulphate. Other ingredients specified are: p-chloro-m-xylenol, esters of hydroxybenzoic acid, imidazolidinyl urea, propylene glycol, hexylene glycol, polyethylene glycol, glucuronic acid, a nucleic acid, a tegobetaine, cystine, cysteine, cysteine hydrochloride, allantoin polygalacturonic acid, allantoin protein, watersoluble protein, hydrolysed protein, placenta extract, pantothenyl alcohol, stearic acid, isopropyl palmitate, glycerol monostearate, cetyl alcohol, ethylene diamine tetraacetic acid, lead acetate, colloidal sulphur, ethanol, glycyrol, hexachlorophene, triethanolamine, spermaceti wax, sodium citrate, mineral oil, lanolin, white petroleum, vitamin E, and gelatin. The compositions disclosed are a scalp lotion, a hair conditioner, a nail hardener, a hair colour restorer, an acne cream, a moisturizing cream and an anti-seborrheic hair conditioner.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4460170A | 1970-06-08 | 1970-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1283892A true GB1283892A (en) | 1972-08-02 |
Family
ID=21933266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB814/71A Expired GB1283892A (en) | 1970-06-08 | 1971-01-07 | Improvements in and relating to medicinal compositions for application to the skin and/or hair |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR2094109B3 (en) |
| GB (1) | GB1283892A (en) |
Cited By (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0035919A3 (en) * | 1980-03-05 | 1982-12-08 | Sophie Frajdenrajch | Composition for treating the hair |
| FR2512669A1 (en) * | 1981-09-14 | 1983-03-18 | Kao Corp | COMPOSITION FOR HAIR TREATMENT |
| EP0095615A3 (en) * | 1982-05-17 | 1984-09-26 | S.C. Johnson & Son, Inc. | Skin conditioning composition |
| JPS61236732A (en) * | 1985-04-05 | 1986-10-22 | フイデイ−ア・ソシエタ・ペル・アチオニ | Novel local medicine |
| EP0283893A1 (en) * | 1987-03-23 | 1988-09-28 | R.P. DENIS S.p.A. | Novel cosmetic formulations |
| US4970220A (en) * | 1982-05-17 | 1990-11-13 | S. C. Johnson & Son, Inc. | Skin conditioning composition |
| AU639975B2 (en) * | 1990-01-30 | 1993-08-12 | Brocades Pharma B.V. | Topical preparations for treating human nails |
| WO1993018736A1 (en) * | 1992-03-19 | 1993-09-30 | Armand Pardo | Cosmetic hair care compositions for treating hair loss |
| US5340579A (en) * | 1984-11-20 | 1994-08-23 | Farmaka S.R.L. | Method of treating dermatological conditions |
| US5442053A (en) * | 1982-09-28 | 1995-08-15 | Fidia, S.P.A. | Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions |
| GB2297762A (en) * | 1994-12-05 | 1996-08-14 | Procter & Gamble | Personal cleaning compositions |
| US5614506A (en) * | 1991-07-03 | 1997-03-25 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5639738A (en) * | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| US5767106A (en) | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
| US5792753A (en) | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
| US5811410A (en) * | 1989-09-21 | 1998-09-22 | Hyal Pharmaceutical Corporation | Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID |
| US5817644A (en) * | 1991-07-03 | 1998-10-06 | Hyal Pharmaceutical Corporation | Targeting of dosages of medicine and therapeutic agents |
| US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
| US5824658A (en) | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5910489A (en) | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5942498A (en) * | 1992-02-20 | 1999-08-24 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5977088A (en) | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5990095A (en) * | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5990096A (en) | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US6022866A (en) * | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US6140312A (en) | 1992-02-20 | 2000-10-31 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| FR2832627A1 (en) * | 2001-11-27 | 2003-05-30 | Phytema | Cosmetic hair treatment composition comprising lead acetate and sulfur, useful for restoring color to gray hair, includes panthenol |
| WO2003002125A3 (en) * | 2001-06-29 | 2003-11-06 | Astion As | Combination of aminosugars and cysteine or cysteine derivatives |
| WO2004000364A1 (en) * | 2002-06-20 | 2003-12-31 | Baas, Fhilipus, Albert | Preparation containing polydimethylsiloxane for nails, cartilage, bone joint, muscle and tendon disorders |
| FR2854573A1 (en) * | 2003-05-06 | 2004-11-12 | Rocher Yves Biolog Vegetale | USE OF OLIGOSACCHARIDES IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS TO STIMULATE THE DIFFERENTIATION OF EPIDERMAL CELLS |
| RU2292906C2 (en) * | 2002-03-05 | 2007-02-10 | Джимонат С.П.А. | Pharmaceutical and cosmetic compositions containing placental growth factor plgf-1 |
| US8758819B2 (en) | 2006-09-13 | 2014-06-24 | Enhance Skin Products, Inc. | Cosmetic compositions for the treatment of skin and methods thereof |
| GB2533527A (en) * | 2015-04-02 | 2016-06-22 | Byotrol Plc | Anti-microbial composition |
| WO2017147067A1 (en) * | 2016-02-22 | 2017-08-31 | Board Of Regents, The University Of Texas System | Antimicrobial compositions and uses thereof |
| IT201600129323A1 (en) * | 2016-12-21 | 2018-06-21 | Medichem S R L | COMPOSITION FOR SHAVING AND ITS PREPARATION METHOD |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4303676A (en) * | 1980-03-21 | 1981-12-01 | Balazs Endre A | Hyaluronate based compositions and cosmetic formulations containing same |
| US4629623A (en) * | 1984-06-11 | 1986-12-16 | Biomatrix, Inc. | Hyaluronate-poly (ethylene oxide) compositions and cosmetic formulations thereof |
| FR2574289B1 (en) * | 1984-12-06 | 1987-03-06 | Roussel Uclaf | NEW COSMETIC COMPOSITIONS FOR SCALP, CONTAINING A COMBINATION BASED ON ACID MUCOPOLYSACCHARIDES AND PEPTIDES, ASSOCIATED WITH A PLACENTARY EXTRACT |
| FR2588756B1 (en) * | 1985-10-18 | 1992-03-20 | Frajdenrajch Sophie | COMPOSITION FOR THE TREATMENT OF HAIR |
| FR2594333B1 (en) * | 1986-02-18 | 1989-05-12 | Etu Physio Hygiene Cosmet Cent | NEW COMPOSITION FOR COSMETIC USE CHARACTERIZED BY THE CONSTITUENTS OF SNAIL EGGS |
| AU610512B2 (en) * | 1986-12-11 | 1991-05-23 | Biomatrix Incorporated | Improved hyaluronate-poly (ethylene oxide) mixtures |
| GB8713747D0 (en) * | 1987-06-12 | 1987-07-15 | Unilever Plc | Skin treatment composition |
| FR2617400B1 (en) * | 1987-07-01 | 1990-09-07 | Tab | ANTI-WRINKLE COSMETIC COMPOSITION FOR TOPICAL APPLICATION |
| DE3742401A1 (en) * | 1987-12-15 | 1989-07-06 | Wella Ag | MEANS AND METHOD FOR PERMANENT HAIR DEFORMING |
| EP0339634A1 (en) * | 1988-04-29 | 1989-11-02 | Estee Lauder Inc. | Post-foaming shave gel composition |
| FR2633829B1 (en) * | 1988-07-07 | 1992-10-02 | Ricaud Labo Biotechno Applic D | COSMETIC COMPOSITION AND HAIR COSMETIC PRODUCT CONTAINING THE SAME |
| IT1228203B (en) * | 1989-01-10 | 1991-06-05 | Promo Int Srl | PRODUCT FOR THE PROTECTION, THE NUTRITION AND, IN GENERAL, THE CARE OF THE HAIR, OF THE LEATHER HAIR, OF THE EYELASHES AND OF THE NAILS. |
| GB2228736A (en) * | 1989-02-10 | 1990-09-05 | Sterivet Lab Ltd | Cosmetic formulation |
| GB8918079D0 (en) * | 1989-08-08 | 1989-09-20 | Unilever Plc | Hair setting composition |
| GB8918080D0 (en) * | 1989-08-08 | 1989-09-20 | Unilever Plc | Hair treatment composition |
| NL1017487C2 (en) * | 2001-03-02 | 2002-09-06 | Caral B V I O | Preparation with polydimethylsiloxane for disorders of nails, cartilage, bones, joints, muscles and tendons. |
-
1971
- 1971-01-07 GB GB814/71A patent/GB1283892A/en not_active Expired
- 1971-06-07 FR FR717120513A patent/FR2094109B3/fr not_active Expired
Cited By (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0035919A3 (en) * | 1980-03-05 | 1982-12-08 | Sophie Frajdenrajch | Composition for treating the hair |
| FR2512669A1 (en) * | 1981-09-14 | 1983-03-18 | Kao Corp | COMPOSITION FOR HAIR TREATMENT |
| EP0095615A3 (en) * | 1982-05-17 | 1984-09-26 | S.C. Johnson & Son, Inc. | Skin conditioning composition |
| US4970220A (en) * | 1982-05-17 | 1990-11-13 | S. C. Johnson & Son, Inc. | Skin conditioning composition |
| US5442053A (en) * | 1982-09-28 | 1995-08-15 | Fidia, S.P.A. | Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions |
| US5631241A (en) * | 1983-10-10 | 1997-05-20 | Fidia S.P.A. | Pharmaceutical compositions containing hyaluronic acid fractions |
| US5340579A (en) * | 1984-11-20 | 1994-08-23 | Farmaka S.R.L. | Method of treating dermatological conditions |
| JPS61236732A (en) * | 1985-04-05 | 1986-10-22 | フイデイ−ア・ソシエタ・ペル・アチオニ | Novel local medicine |
| EP0283893A1 (en) * | 1987-03-23 | 1988-09-28 | R.P. DENIS S.p.A. | Novel cosmetic formulations |
| US5811410A (en) * | 1989-09-21 | 1998-09-22 | Hyal Pharmaceutical Corporation | Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID |
| US5929048A (en) * | 1989-09-21 | 1999-07-27 | Hyal Pharmaceutical Corporation | Treatment of conditions and disease |
| US5985851A (en) * | 1989-09-21 | 1999-11-16 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof |
| US6194392B1 (en) | 1989-09-21 | 2001-02-27 | Hyal Pharmaceutical Corporation | Treatment of conditions and disease |
| US5985850A (en) * | 1989-09-21 | 1999-11-16 | Hyal Pharmaceuticals Corporation | Compositions comprising hyaluronic acid and drugs |
| US6048844A (en) * | 1989-09-21 | 2000-04-11 | Hyal Pharmaceutical Corporation | Treatment of conditions and disease |
| US5932560A (en) * | 1989-09-21 | 1999-08-03 | Hyal Pharmaceutical Corporation | Treatment of conditions and disease |
| US6069135A (en) * | 1989-09-21 | 2000-05-30 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents |
| US5914314A (en) * | 1989-09-21 | 1999-06-22 | Hyal Pharmaceutical Corporation | Use of a form of hyaluronic acid and a medicinal agent for reducing rejection of organs transplantation in mammals |
| US5852002A (en) * | 1989-09-21 | 1998-12-22 | Hyal Pharmaceutical Corporation | Treatment of conditions and disease |
| US5830882A (en) * | 1989-09-21 | 1998-11-03 | Hyal Pharmaceutical Corporation | Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition |
| US5827834A (en) * | 1989-09-21 | 1998-10-27 | Hyal Pharmaceutical Corporation | Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease |
| AU639975B2 (en) * | 1990-01-30 | 1993-08-12 | Brocades Pharma B.V. | Topical preparations for treating human nails |
| US5824658A (en) | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5910489A (en) | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5990096A (en) | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5962433A (en) | 1990-09-18 | 1999-10-05 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US6022866A (en) * | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5817644A (en) * | 1991-07-03 | 1998-10-06 | Hyal Pharmaceutical Corporation | Targeting of dosages of medicine and therapeutic agents |
| US5990095A (en) * | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5792753A (en) | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
| US5977088A (en) | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5614506A (en) * | 1991-07-03 | 1997-03-25 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5639738A (en) * | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| US6140312A (en) | 1992-02-20 | 2000-10-31 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US6147059A (en) * | 1992-02-20 | 2000-11-14 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5942498A (en) * | 1992-02-20 | 1999-08-24 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5767106A (en) | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
| WO1993018736A1 (en) * | 1992-03-19 | 1993-09-30 | Armand Pardo | Cosmetic hair care compositions for treating hair loss |
| GB2297762A (en) * | 1994-12-05 | 1996-08-14 | Procter & Gamble | Personal cleaning compositions |
| US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
| WO2003002125A3 (en) * | 2001-06-29 | 2003-11-06 | Astion As | Combination of aminosugars and cysteine or cysteine derivatives |
| FR2832627A1 (en) * | 2001-11-27 | 2003-05-30 | Phytema | Cosmetic hair treatment composition comprising lead acetate and sulfur, useful for restoring color to gray hair, includes panthenol |
| WO2003045343A1 (en) * | 2001-11-27 | 2003-06-05 | Emile Orenga | Cosmetic composition for hair treatment |
| RU2292906C2 (en) * | 2002-03-05 | 2007-02-10 | Джимонат С.П.А. | Pharmaceutical and cosmetic compositions containing placental growth factor plgf-1 |
| WO2004000364A1 (en) * | 2002-06-20 | 2003-12-31 | Baas, Fhilipus, Albert | Preparation containing polydimethylsiloxane for nails, cartilage, bone joint, muscle and tendon disorders |
| EP1374904A1 (en) * | 2002-06-20 | 2004-01-02 | Baas, Fhilipus Albert | Preparation containing polymethyl-siloxane for nails, cartilage, bone joint, muscle and tendon disorders |
| FR2854573A1 (en) * | 2003-05-06 | 2004-11-12 | Rocher Yves Biolog Vegetale | USE OF OLIGOSACCHARIDES IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS TO STIMULATE THE DIFFERENTIATION OF EPIDERMAL CELLS |
| WO2004098543A3 (en) * | 2003-05-06 | 2005-02-10 | Rocher Yves Biolog Vegetale | Use of oligogalacturonide-type oligosaccharides in cosmetic, food or dermatological compositions in order to stimulate epidermal cell differentiation |
| US8758819B2 (en) | 2006-09-13 | 2014-06-24 | Enhance Skin Products, Inc. | Cosmetic compositions for the treatment of skin and methods thereof |
| GB2533527A (en) * | 2015-04-02 | 2016-06-22 | Byotrol Plc | Anti-microbial composition |
| GB2533527B (en) * | 2015-04-02 | 2018-10-17 | Byotrol Plc | Anti-microbial composition |
| WO2017147067A1 (en) * | 2016-02-22 | 2017-08-31 | Board Of Regents, The University Of Texas System | Antimicrobial compositions and uses thereof |
| US11065223B2 (en) | 2016-02-22 | 2021-07-20 | Board Of Regents, The University Of Texas System | Antimicrobial compositions and uses thereof |
| US11826332B2 (en) | 2016-02-22 | 2023-11-28 | Board Of Regents, The University Of Texas System | Antimicrobial compositions and uses thereof |
| IT201600129323A1 (en) * | 2016-12-21 | 2018-06-21 | Medichem S R L | COMPOSITION FOR SHAVING AND ITS PREPARATION METHOD |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2094109B3 (en) | 1973-08-10 |
| FR2094109A7 (en) | 1972-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1283892A (en) | Improvements in and relating to medicinal compositions for application to the skin and/or hair | |
| US4490355A (en) | Betaine based cosmetic formulations | |
| US4839164A (en) | Trehalose containing cosmetic composition and method of using it | |
| US5153174A (en) | Polymer mixtures useful in skin care | |
| US20040081672A1 (en) | Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging | |
| GB1497950A (en) | Cosmetic compositions based on enzymes | |
| US20040241114A1 (en) | Hair Care and Nail Care Compositions Based on Ion-Pair Delivery System for Gender and Ethnic Selective Applications | |
| GB1513659A (en) | Cosmetics | |
| US20190053997A1 (en) | Skin care cosmetic set and application method thereof | |
| AU5342694A (en) | Cosmetic composition | |
| ES8308212A1 (en) | Topical antimicrobial composition. | |
| CA2144509A1 (en) | Skin-conditioning composition, its application and manufacture | |
| EP2793833A2 (en) | Topical oil composition for the treatment of fungal infections | |
| US8372383B2 (en) | Agent for inducing hair growth containing extracts of saw palmetto and swertia | |
| EP0219455A3 (en) | Pharmaceutical and cosmetic compositions containing n-acetylcysteine | |
| EP3403642A1 (en) | Cosmetic | |
| GB2074444A (en) | Anti-dandruff compositions containing biguanidines | |
| GB1422642A (en) | Cosmetic preparations | |
| GB1051268A (en) | Hair treating compositions | |
| IE32342B1 (en) | Polypeptide lotion | |
| JP3784442B2 (en) | Topical skin preparation | |
| EP0067658A2 (en) | Carboxyvinyl polymer urea gel compositions | |
| JPS59118702A (en) | Cosmetic | |
| GB1356635A (en) | Deodorising and anti-seborrhoeic compositions | |
| ITMI970339A1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRO AND USE OF COLOSTRO FOR HAIR LOSS TREATMENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 414F | Notice of opposition given (sect. 14/1949) | ||
| 414A | Case decided by the comptroller ** specification amended (sect. 14/1949) | ||
| SPA | Amended specification published | ||
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |